Barbara Savoldo

23.9k citations

207 papers · 16.6k indexed · 9 hit papers · h-index 66

Impact in

Oncology top 0.05%
- CAR-T cell therapy research
Immunology top 0.1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Oncology 175
- CAR-T cell therapy research 152
- Viral-associated cancers and disorders 22
Immunology 96
- Immune Cell Function and Interaction 61
- Immunotherapy and Immune Responses 39
- T-cell and B-cell Immunology 32

Co-authors: Gianpietro Dotti Malcolm K. Brenner Cliona M. Rooney Helen E. HeslopHao LiuAdrian P. Gee Enli Liu Zhuyong Mei
Journals: Blood (58 papers)Clinical Cancer Research (12 papers)Molecular Therapy (10 papers)Cancer Immunology Research (7 papers)Journal of Clinical Investigation (7 papers)
Partner nations: United States Italy Germany

In The Last Decade

Barbara Savoldo

198 papers receiving 16.4k citations

Hit Papers

9 papers align trajectories log scale

Immunogenicity of CAR T cells in cancer therapy 2021 · 208 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature Reviews Clinical Oncology
2017 Molecular Therapy
2015 Nature Medicine
2014 Blood
2013 Immunological Reviews
2011 Blood
2011 Journal of Clinical Investigation
2011 New England Journal of Medicine
2008 Nature Medicine

Peers

Countries citing papers authored by Barbara Savoldo

Since Specialization

Citations

This map shows the geographic impact of Barbara Savoldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Savoldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Savoldo more than expected).

Fields of papers citing papers by Barbara Savoldo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Savoldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Savoldo. The network helps show where Barbara Savoldo may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Savoldo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Savoldo Line = papers co-authored together Barbara Savoldo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/ Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma Transplantation and Cellular Therapy ·Natalie S. Grover, Anastasia Ivanova, Dominic Moore, Catherine Cheng, Caroline Babinec, John B. West, Tammy A Cavallo, J. Kaitlin Morrison, Faith Brianne Buchanan, Edith V. Bowers, Christopher Dittus, Anne Beaven, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo	2022	2
2	CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells Clinical Cancer Research ·Raghuveer Ranganathan, Peishun Shou, Sarah Ahn, Chuang Sun, John A. West, Barbara Savoldo, Gianpietro Dotti	2021	18
3	Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy Blood Cancer Discovery ·Mohamed Abou‐El‐Enein, Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks, Brian G. Till, Gerhard Bauer, Barbara Savoldo	2021	182
4	Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia Clinical Cancer Research ·Eben I. Lichtman, Hongwei Du, Peishun Shou, Feifei Song, Kyogo Suzuki, Sarah Ahn, Guangming Li, Soldano Ferrone, Lishan Su, Barbara Savoldo, Gianpietro Dotti	2021	57
5	Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling Cancer Immunology Research ·Elisa Landoni, Giovanni Fucà, Jian Wang, Venkat R. Chirasani, Zhiyuan Yao, Elena Dukhovlinova, Soldano Ferrone, Barbara Savoldo, Lee K. Hong, Peishun Shou, Silvia Musio, Francesco Padelli, Gaetano Finocchiaro, Miriam Droste, Brian Kuhlman, Abdijapar Shamshiev, Serena Pellegatta, Nikolay V. Dokholyan, Gianpietro Dotti	2021	56
6	Infusion of CD30 CAR T Cells Is Safe and Effective As Consolidation Following Autologous Hematopoietic Stem Cell Transplant Transplantation and Cellular Therapy ·Marcie Riches, Thomas C. Shea, Anastasia Ivanova, Catherine Cheng, Spencer Laing, Mary Beth Seegars, Gianpietro Dotti, Barbara Savoldo, Natalie S. Grover, Jonathan S. Serody	2021	3
7	Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies Cancer Immunology Research ·Sarah Ahn, Jingjing Li, Chuang Sun, Keliang Gao, Koichi Hirabayashi, Hongxia Li, Barbara Savoldo, Rihe Liu, Gianpietro Dotti	2019	20
8	A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor Cancer Immunology Research ·Elisa Landoni, Christof C. Smith, Giovanni Fucà, Yu‐Hui Chen, Chuang Sun, Benjamin G. Vincent, Leonid S. Metelitsa, Gianpietro Dotti, Barbara Savoldo	2019	12
9	NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma Clinical Cancer Research ·Xin Xu, Wei Huang, Andras Heczey, Daofeng Liu, Linjie Guo, Michael S. Wood, Jingling Jin, Amy N. Courtney, Bin Liu, Erica J. Di Pierro, John Hicks, Gabriel A. Barragán, Ho Ngai, Yu‐Hui Chen, Barbara Savoldo, Gianpietro Dotti, Leonid S. Metelitsa	2019	133
10	Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes Cancer Immunology Research ·Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, Benjamin G. Vincent	2019	47
11	Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15 Clinical Cancer Research ·Yu‐Hui Chen, Chuang Sun, Elisa Landoni, Leonid S. Metelitsa, Gianpietro Dotti, Barbara Savoldo	2019	159
12	A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia Clinical Cancer Research ·Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Jessica Wenthe, Tanja Lövgren, Rose‐Marie Amini, Kristina Wikström, Magnus Essand, Barbara Savoldo, Heléne Hallböök, Martin Höglund, Gianpietro Dotti, Malcolm K. Brenner, Hans Hagberg, Angelica Loskog	2018	207
13	CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30− Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions Cancer Immunology Research ·Lee K. Hong, Yu‐Hui Chen, Christof C. Smith, Stephanie A. Montgomery, Benjamin G. Vincent, Gianpietro Dotti, Barbara Savoldo	2018	59
14	K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo Clinical Cancer Research ·Ignazio Caruana, Gerrit Weber, Brandon C. Ballard, Michael S. Wood, Barbara Savoldo, Gianpietro Dotti	2015	32
15	Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity Clinical Cancer Research ·Alana A. Kennedy‐Nasser, Stephanie Ku, Paul Castillo‐Caro, Yasmin Hazrat, Meng-Fen Wu, Hao Liu, Jos Melenhorst, A. John Barrett, Sawa Ito, Aaron E. Foster, Barbara Savoldo, Eric Yvon, George Carrum, Carlos A. Ramos, Robert A. Krance, Kathryn Leung, Helen E. Heslop, Malcolm K. Brenner, Catherine M. Bollard	2014	145
16	Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor–Modified T Cells in Solid Tumors Cancer Research ·Nobuhiro Nishio, Iulia Diaconu, Hao Liu, Vincenzo Cerullo, Ignazio Caruana, Valentina Hoyos, Lisa Bouchier‐Hayes, Barbara Savoldo, Gianpietro Dotti	2014	272
17	T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo Clinical Cancer Research ·Claudia Geldres, Barbara Savoldo, Valentina Hoyos, Ignazio Caruana, Ming Zhang, Eric Yvon, Michele Del Vecchio, Chad J. Creighton, Michael Ittmann, Soldano Ferrone, Gianpietro Dotti	2013	80
18	Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition Clinical Cancer Research ·Serena Perna, Daria Pagliara, Aruna Mahendravada, Hao Liu, Malcolm K. Brenner, Barbara Savoldo, Gianpietro Dotti	2013	115
19	Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma Clinical Cancer Research ·Serena Perna, Biagio De Angelis, Daria Pagliara, Sayyeda T. Hasan, Lan Zhang, Aruna Mahendravada, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Gianpietro Dotti, Barbara Savoldo	2012	63
20	Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells Clinical Cancer Research ·Eric Yvon, Michele Del Vecchio, Barbara Savoldo, Valentina Hoyos, Aurélie Dutour, Andrea Anichini, Gianpietro Dotti, Malcolm K. Brenner	2009	113

About Barbara Savoldo

Barbara Savoldo is a scholar working on Oncology, Immunology, Hematology, Genetics and Genetics, having authored 207 papers that have together received 16.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (152 papers), Immune Cell Function and Interaction (61 papers), Virus-based gene therapy research (49 papers), Immunotherapy and Immune Responses (39 papers), T-cell and B-cell Immunology (32 papers), Cytomegalovirus and herpesvirus research (24 papers), Viral-associated cancers and disorders (22 papers) and Lymphoma Diagnosis and Treatment (21 papers). The work is most often cited by research in Oncology (14.0k citations), Immunology (6.5k citations), Genetics (4.8k citations), Hematology (1.1k citations) and Biomedical Engineering (3.8k citations). Barbara Savoldo has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Gianpietro Dotti, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Hao Liu, Adrian P. Gee, Enli Liu, Zhuyong Mei, Carlos A. Ramos and Valentina Hoyos. Their work appears in journals such as Blood, Clinical Cancer Research, Molecular Therapy, Cancer Immunology Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact